The synthesis of complex pharmaceutical APIs is heavily reliant on the quality and purity of the chemical intermediates employed. Tofacitinib Citrate, a significant therapeutic agent for managing autoimmune diseases, exemplifies this principle. The efficacy and safety of the final Tofacitinib Citrate product are intrinsically linked to the characteristics of its precursors, particularly intermediates like N-Methyl-N-[(3R,4R)-4-Methyl-1-(Phenylmethyl)-3-Piperidinyl]-7-((4-Methylphenyl) Sulfonyl)-7H-Pyrrolo[2,3-d]Pyrimidin-4-Amine, identified by CAS number 923036-30-0. This article aims to shed light on the critical importance of purity in these intermediates and outline effective sourcing strategies.
The Imperative of Purity in Pharmaceutical Intermediates
In pharmaceutical synthesis, purity is not merely a desirable attribute; it is a fundamental requirement. For intermediates like CAS 923036-30-0, any deviation in purity or the presence of unwanted stereoisomers can compromise the entire synthesis process. This can lead to reduced API yield, difficulties in purification, and, most importantly, potential safety concerns for patients. R&D scientists and quality control teams meticulously analyze intermediates to ensure they meet stringent specifications. Therefore, when a procurement manager looks to buy Tofacitinib Citrate intermediate, the supplier’s commitment to purity assurance is a primary selection criterion.
Effective Sourcing Strategies for Tofacitinib Intermediates
Securing a consistent supply of high-quality Tofacitinib Citrate intermediate requires a strategic approach to sourcing. Key considerations include:
NINGBO INNO PHARMCHEM CO.,LTD. – Your Partner in Purity and Reliability
As a dedicated Tofacitinib intermediate manufacturer and supplier, we at NINGBO INNO PHARMCHEM CO.,LTD. place immense importance on the purity and quality of our products. Our CAS 923036-30-0 intermediate is produced under strict quality controls to meet the demanding specifications of the pharmaceutical industry. We are committed to being a dependable source for companies looking to purchase essential Tofacitinib intermediates, contributing to the development and availability of critical medications.
In conclusion, the quality of Tofacitinib Citrate intermediates is inextricably linked to the success of the final API. By adopting a rigorous approach to supplier selection and prioritizing purity, pharmaceutical companies can ensure the efficiency and integrity of their manufacturing processes.
Manufacturing Facilities






Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.